Dysmenorrhea Symptoms And Gut Microbiome: A Pilot Study

Chen Chen,Janet S. Carpenter,Andrea Shin,Tzu-Wen L. Cross,Yuzhen Ye,Caroline Mitchell,J. Dennis Fortenberry
DOI: https://doi.org/10.1016/j.jpain.2023.02.009
2023-04-01
Abstract:Dysmenorrhea is highly prevalent among reproductive-age women and can increase their risks for other chronic pain conditions. Although dysmenorrhea is characterized by menstrual pain, individuals differ in pain severity, the number of painful sites, and co-occurring gastrointestinal symptoms. Mechanisms underlying individual differences in dysmenorrhea symptoms are not well understood. As the gut microbiota has been linked to pain and gastrointestinal symptoms in other health conditions, gut microbiome may be a promising avenue to study individual differences in dysmenorrhea. This study aimed to examine associations between dysmenorrhea symptoms and gut microbiome. In a prospective longitudinal pilot study, 20 participants with dysmenorrhea (aged 15-24) self-collected stool samples when on-menses and at mid-cycle. Shotgun metagenomic sequencing was used to characterize gut microbiome features. Spearman's correlation and heatmaps were used to assess associations between dysmenorrhea symptoms and gut microbial features (taxa and functional pathways) in on-menses and mid-cycle samples. Multiple testings were corrected using the Benjamini-Hochberg procedure controlling for false-discovery-rate. Gut microbial taxa were not significantly correlated with dysmenorrhea symptom severity; however, multiple gut microbial functional pathways in the on-menses samples were significantly correlated with dysmenorrhea symptom severity scores (q value<0.2). For example, L-histidine biosynthesis, aspartate superpathway, and L-methionine biosynthesis pathways were positively associated with dysmenorrhea symptom severity (Rho's>0.4). We found trends in associations between dysmenorrhea symptoms and gut microbial functional pathways. If these preliminary findings can be confirmed in a larger study that includes metabolomic data, they can potentially inform the development of interventions for dysmenorrhea symptoms. KL2TR001106 and UL1TR001108.
neurosciences,clinical neurology
What problem does this paper attempt to address?